MarketPeel
Insider Trading Intelligence
Pricing
…
FA

Faraz Ali

TNYA
CHIEF EXECUTIVE OFFICER · TENAYA THERAPEUTICS, INC. · CIK 0001667937
FILING MIX · LIFETIME42%/58%
BUYS
13
SELLS
18
TOTAL VALUE
$127.9K
COMPANIES
1
ACTIVE SINCE
Feb 2022
HOLDINGS NOW
440,014
AVG SELL PX
$1.81
TRADE KIND
SHOWING 31 / 31
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
14 backtested trades · 8 horizons · 22 pending
Forward-return performance of every backtestable P/S trade by Faraz Ali, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d14+78.57%+1.76%+0.51%+1.26%-3.65%—
14d14+57.14%-0.24%+0.92%-1.16%-8.96%—
30d14+71.43%-4.28%+0.23%-4.50%-7.24%—
60d14+50.00%+1.77%+3.06%-1.29%+0.39%—
90d14+35.71%+7.02%+6.10%+0.92%-3.48%—
180d14(3 pending)+63.64%+23.99%+10.87%+13.12%-53.60%—
1y14(7 pending)+57.14%+6.51%+21.83%-15.31%-49.44%—
2y14(12 pending)+100.00%-79.67%+44.23%-123.90%-123.90%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TNYA · 440,014 shares · as of May 18, 2026
0238,063476,125714,188952,2502023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 13 buys / 18 sellsCOVERAGE · 18 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TNYA
TENAYA THERAPEUTICS, INC.
SALE
Chief Executive Officer
3,390$0.79$2.7K440,014May 18, 2026May 19, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
Chief Executive Officer
3,979$0.64$2.6K448,436Feb 17, 2026Feb 17, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
Chief Executive Officer
5,851$0.64$3.8K452,415Feb 17, 2026Feb 17, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
Chief Executive Officer
5,032$0.64$3.2K443,404Feb 17, 2026Feb 17, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
952,250——952,250Feb 3, 2026Feb 5, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
158,600——458,266Feb 3, 2026Feb 5, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
Chief Executive Officer
3,126$1.33$4.2K299,666Nov 17, 2025Nov 17, 2025 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
Chief Executive Officer
3,893$1.25$4.9K307,712Aug 18, 2025Aug 18, 2025 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
Chief Executive Officer
5,720$1.25$7.2K311,605Aug 18, 2025Aug 18, 2025 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
Chief Executive Officer
4,920$1.25$6.2K302,792Aug 18, 2025Aug 18, 2025 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
Chief Executive Officer
3,189$0.44$1.4K317,325May 16, 2025May 16, 2025 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
Chief Executive Officer
3,947$0.54$2.1K320,514Mar 10, 2025Mar 10, 2025 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
Chief Executive Officer
5,794$0.54$3.1K324,461Mar 10, 2025Mar 10, 2025 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
161,214——161,214Feb 6, 2025Feb 7, 2025 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
107,500——295,831Feb 6, 2025Feb 7, 2025 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
650,000——650,000Feb 6, 2025Feb 7, 2025 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
401,390——401,390Feb 6, 2025Feb 7, 2025 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
Chief Executive Officer
401,390——0Feb 6, 2025Feb 7, 2025 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
34,424——330,255Feb 6, 2025Feb 7, 2025 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
Chief Executive Officer
161,214——0Feb 6, 2025Feb 7, 2025 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
Chief Executive Officer
353,271——0Feb 6, 2025Feb 7, 2025 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
353,271——353,271Feb 6, 2025Feb 7, 2025 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
Chief Executive Officer
5,802$2.89$16.8K192,277Aug 16, 2024Aug 16, 2024 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
Chief Executive Officer
3,946$2.89$11.4K188,331Aug 16, 2024Aug 16, 2024 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
505,000——505,000Feb 23, 2024Feb 27, 2024 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
85,000——198,079Feb 23, 2024Feb 27, 2024 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
Chief Executive Officer
6,358$5.86$37.3K113,079Feb 16, 2024Feb 16, 2024 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
Chief Executive Officer
5,563$3.81$21.2K119,437Aug 16, 2023Aug 18, 2023 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
125,000——125,000Feb 15, 2023Feb 17, 2023 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
675,000——675,000Feb 15, 2023Feb 17, 2023 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
401,390——401,390Feb 15, 2022Feb 17, 2022 ↗View →
Other insiders · TNYA
Loading peer insiders…
About this filer
CIK 0001667937
ROLE
Chief Executive Officer
PRIMARY
TNYA
COMPANIES
1
ACTIVE SINCE
Feb 2022
MARKETPEEL · /INSIDER/0001667937DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback